Evidence map›Paper›PMID 37095919›Full record

ReviewHeliyon2023

Wei Pan, Binshu Chai, Langping Li, Zhijun Lu, Zhongliang Ma

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Cells · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wei PanLab of Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Binshu ChaiLab of Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, China.
Langping LiDepartment of Anesthesiology, Ruijin Hospital/Luwan Branch, Shanghai Jiao Tong University, School of Medicine, Shanghai 200020, China.
Zhijun LuDepartment of Anesthesiology, Ruijin Hospital/Luwan Branch, Shanghai Jiao Tong University, School of Medicine, Shanghai 200020, China.
Zhongliang MaLab of Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer is serious endangers human life. After a long period of research and accumulation, people's understanding of cancer and the corresponding treatment methods are constantly developing.

Indexed as

miR-34p53Signaling pathwayTumor

Identifiers

PMID37095919
PMCPMC10121403

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.